ID: ALA4216404

Max Phase: Preclinical

Molecular Formula: C36H38N4O5

Molecular Weight: 606.72

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C)cc(C(=O)N[C@H](Cc2ccc(-c3ccc(CN(C)C)o3)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1

Standard InChI:  InChI=1S/C36H38N4O5/c1-22-15-23(2)17-26(16-22)34(41)38-31(18-24-9-11-25(12-10-24)33-14-13-28(45-33)21-40(3)4)35(42)39-32(36(43)44)19-27-20-37-30-8-6-5-7-29(27)30/h5-17,20,31-32,37H,18-19,21H2,1-4H3,(H,38,41)(H,39,42)(H,43,44)/t31-,32+/m1/s1

Standard InChI Key:  BJKXACGHFGVIHK-ZWXJPIIXSA-N

Associated Targets(Human)

Hemoglobin HbA 880 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 606.72Molecular Weight (Monoisotopic): 606.2842AlogP: 5.26#Rotatable Bonds: 12
Polar Surface Area: 127.67Molecular Species: ACIDHBA: 5HBD: 4
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.86CX Basic pKa: 8.26CX LogP: 2.84CX LogD: 2.79
Aromatic Rings: 5Heavy Atoms: 45QED Weighted: 0.15Np Likeness Score: -0.54

References

1. Goldstein SR, Liu C, Safo MK, Nakagawa A, Zapol WM, Winkler JD..  (2018)  Design, Synthesis, and Biological Evaluation of Allosteric Effectors That Enhance CO Release from Carboxyhemoglobin.,  (7): [PMID:30034606] [10.1021/acsmedchemlett.8b00166]

Source